An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior
An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior
Understanding the role of SCN8A in epilepsy and behavior is critical in light of recently identified human SCN8A epilepsy mutations. We have previously demonstrated that Scn8a(med) and Scn8a(med-jo) mice carrying mutations in the Scn8a gene display increased resistance to flurothyl and kainic acid-induced seizures; however, they also exhibit spontaneous absence seizures. To further investigate the relationship between altered SCN8A function and epilepsy, we introduced the SCN1A-R1648H mutation, identified in a family with generalized epilepsy with febrile seizures plus (GEFS+), into the corresponding position (R1627H) of the mouse Scn8a gene. Heterozygous R1627H mice exhibited increased resistance to some forms of pharmacologically and electrically induced seizures and the mutant Scn8a allele ameliorated the phenotype of Scn1a-R1648H mutants. Hippocampal slices from heterozygous R1627H mice displayed decreased bursting behavior compared to wild-type littermates. Paradoxically, at the homozygous level, R1627H mice did not display increased seizure resistance and were susceptible to audiogenic seizures. We furthermore observed increased hippocampal pyramidal cell excitability in heterozygous and homozygous Scn8a-R1627H mutants, and decreased interneuron excitability in heterozygous Scn8a-R1627H mutants. These results expand the phenotypes associated with disruption of the Scn8a gene and demonstrate that an Scn8a mutation can both confer seizure protection and increase seizure susceptibility.
- Emory University United States
- The Wallace H. Coulter Department of Biomedical Engineering United States
- University of California, San Francisco United States
- Georgia Institute of Technology United States
- University of California, Irvine United States
GEFS+, Male, Audiogenic seizure, Knockout, Oncology and Carcinogenesis, Clinical Sciences, Na(v)1.6, GEFS, Na(v)1.1, Neurodegenerative, Hippocampus, Interneuron, Mice, Voltage sensor, Interneurons, Seizures, Genetics, 2.1 Biological and endogenous factors, Psychology, Animals, Aetiology, Mice, Knockout, Epilepsy, Neurology & Neurosurgery, Biomedical and Clinical Sciences, Sodium channel, Pyramidal Cells, Neurosciences, Dravet syndrome, Brain Disorders, Acoustic Stimulation, NAV1.6 Voltage-Gated Sodium Channel, Neurological, Mutation, Biological psychology, Disease Susceptibility, Brain Stem
GEFS+, Male, Audiogenic seizure, Knockout, Oncology and Carcinogenesis, Clinical Sciences, Na(v)1.6, GEFS, Na(v)1.1, Neurodegenerative, Hippocampus, Interneuron, Mice, Voltage sensor, Interneurons, Seizures, Genetics, 2.1 Biological and endogenous factors, Psychology, Animals, Aetiology, Mice, Knockout, Epilepsy, Neurology & Neurosurgery, Biomedical and Clinical Sciences, Sodium channel, Pyramidal Cells, Neurosciences, Dravet syndrome, Brain Disorders, Acoustic Stimulation, NAV1.6 Voltage-Gated Sodium Channel, Neurological, Mutation, Biological psychology, Disease Susceptibility, Brain Stem
19 Research products, page 1 of 2
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
chevron_left - 1
- 2
chevron_right
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).22 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
